Cargando…

Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

Metastatic relapse after treatment is the leading cause of cancer mortality, and known resistance mechanisms are missing for most treatments administered to patients. To bridge this gap, we analyze a pan-cancer cohort (META-PRISM) of 1,031 refractory metastatic tumors profiled via whole-exome and tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pradat, Yoann, Viot, Julien, Yurchenko, Andrey A., Gunbin, Konstantin, Cerbone, Luigi, Deloger, Marc, Grisay, Guillaume, Verlingue, Loic, Scott, Véronique, Padioleau, Ismael, Panunzi, Leonardo, Michiels, Stefan, Hollebecque, Antoine, Jules-Clément, Gérôme, Mezquita, Laura, Lainé, Antoine, Loriot, Yohann, Besse, Benjamin, Friboulet, Luc, André, Fabrice, Cournède, Paul-Henry, Gautheret, Daniel, Nikolaev, Sergey I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157368/ https://www.ncbi.nlm.nih.gov/pubmed/36862804 http://dx.doi.org/10.1158/2159-8290.CD-22-0966

Ejemplares similares

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer
por: Facchinetti, Francesco, et al.
Publicado: (2023)

CustOmics: A versatile deep-learning based strategy for multi-omics integration
por: Benkirane, Hakim, et al.
Publicado: (2023)

Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients
por: Yurchenko, Andrey A., et al.
Publicado: (2023)

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report
por: Enrico, Diego, et al.
Publicado: (2020)

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
por: Recondo, Gonzalo, et al.
Publicado: (2020)

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
por: Bayle, Arnaud, et al.
Publicado: (2021)

XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature
por: Yurchenko, Andrey A., et al.
Publicado: (2020)

Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study
por: Bayle, Arnaud, et al.
Publicado: (2023)

The contribution of uncharted RNA sequences to tumor identity in lung adenocarcinoma
por: Wang, Yunfeng, et al.
Publicado: (2022)

1617P Sustained cancer clinical trial activity during the COVID-19 pandemic
por: Bayle, A., et al.
Publicado: (2021)

Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score
por: Pierro, Monica, et al.
Publicado: (2022)

Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test
por: Vasseur, Damien, et al.
Publicado: (2022)

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume
por: Belkouchi, Younes, et al.
Publicado: (2022)

BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?
por: Lebacle, Cedric, et al.
Publicado: (2021)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
por: Dubuquoy, Laurent, et al.
Publicado: (2009)

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma
por: Parent, Pauline, et al.
Publicado: (2023)

Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176
por: Auclin, Edouard, et al.
Publicado: (2021)

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers
por: Cabel, Luc, et al.
Publicado: (2018)

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
por: Fizazi, Karim, et al.
Publicado: (2015)

Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic
por: Lenfant, Louis, et al.
Publicado: (2020)

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer
por: Schernberg, Antoine, et al.
Publicado: (2018)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic Review
por: Duquesne, Igor, et al.
Publicado: (2019)

Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data
por: Rivera, Caroline, et al.
Publicado: (2011)

Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors
por: Auclin, Edouard, et al.
Publicado: (2021)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
por: Liu, Peng, et al.
Publicado: (2022)

Development and Validation of a Bedside Score to Predict Early Death in Cancer of Unknown Primary Patients
por: Penel, Nicolas, et al.
Publicado: (2009)

Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers
por: Nebot-Bral, Laetitia, et al.
Publicado: (2022)

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?
por: Aldea, M., et al.
Publicado: (2023)

Radon and Lung Cancer: Current Trends and Future Perspectives
por: Riudavets, Mariona, et al.
Publicado: (2022)

Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
por: Fidelle, Marine, et al.
Publicado: (2020)

Complete Genome Sequences of Two Newcastle Disease Virus Strains Isolated from a Wild Duck and a Pigeon in Russia
por: Kabilov, Marsel R., et al.
Publicado: (2016)

A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events
por: Li, Jia, et al.
Publicado: (2015)

Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
por: Facchinetti, Francesco, et al.
Publicado: (2019)

Use of Gentamicin for Sepsis and Septic Shock in Anaesthesia-Intensive Care Unit: A Clinical Practice Evaluation
por: Pernod, Cyril, et al.
Publicado: (2020)

Modeling tree crown dynamics with 3D partial differential equations
por: Beyer, Robert, et al.
Publicado: (2014)

Leaf Segmentation and Tracking in Arabidopsis thaliana Combined to an Organ-Scale Plant Model for Genotypic Differentiation
por: Viaud, Gautier, et al.
Publicado: (2017)

Method for semi-automated microscopy of filtration-enriched circulating tumor cells
por: Pailler, Emma, et al.
Publicado: (2016)

Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
por: Cartry, Jérôme, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ugoophqv6o24lnldu95vttlsp2